Heart Failure: Advanced Development in Genetics and Epigenetics

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Gene</td><td align="center">Protein </td><td align="center">OMIM</td><td align="center">% of familial ARVC cases</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">DSP</td><td align="center">Desmoplakin</td><td align="center">125647</td><td align="center">6%–16%</td></tr><tr><td align="left">PKP2</td><td align="center">Plakophilin 2</td><td align="center">602861</td><td align="center">11%–43%</td></tr><tr><td align="left">DSG2</td><td align="center">Desmoglein 2</td><td align="center">125671</td><td align="center">12%–40%</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Main arrhythmogenic right ventricular cardiomyopathy-causing genes hypertrophic cardiomyopathy.

BioMed Research International

tab3

Table 3

Table 3: Heart Failure: Advanced Development in Genetics and Epigenetics 